| Project/Area Number |
24659256
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Applied pharmacology
|
|---|
| Research Institution | University of Tsukuba |
|---|
Principal Investigator |
KOHDA Yukinao 筑波大学, 医学医療系, 教授 (40143482)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
MOMO Kenji 筑波大学, 附属病院, 病院講師 (30645552)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2012: ¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
|
|---|
| Keywords | 応用薬理学 / 副作用 / 薬物動態 / 薬物相互作用 / Cytochrome P450 1A2 |
|---|
| Research Abstract |
In the patients treated with tizanidine, approximately 45 % of the patients were co-administered with CYP1A2 inhibitors. Adverse effects induced co-administration of CYP1A2 inhibitors were observed in 23% of these patients. Tizanidine and cimetidine co-administration study was conducted in 6 healthy subjects. The prediction of adverse effects induced by tizanidine in the patients treated with tizanidine and cimetidine wereapplicable by using these data.
|
